Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma;Tomographie par émission de positons et fusion d'images de simulation virtuelle par tomodensitométrie. Impact sur la planification de la radiothérapie conformationnelle des cancers de l'œsophage

Cancer/Radiotherapie

Volumn 9, Issue 3, 2005, Pages 152-160

  Moureau Zabotto, L ^a   Touboul, E ^a   Lerouge, D ^a   Deniaud Alexandre, E ^a   Grahek, D ^a   Foulquier, J N ^a   Petenief, Y ^a   Gres B ^a   El Balaa, H ^a   Kerrou, K ^a   Montravers, F ^a   Keraudy, K ^a   Tiret, E ^b   Gendre, J P ^b   Grange, J D ^a   Hourry, S ^a   Talbot, J N ^a  

^a HÔPITAL TENON   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

18F deoxyglucose PET imaging; Computed tomography; Conformal radiotherapy; Esophageal carcinoma; Image fusion

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; LUNG VOLUME; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SIMULATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; CARCINOMA; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PATIENT CARE PLANNING; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 22144475099     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.04.001     Document Type: Article

References (43)

1. 18F-FDG detection with a dual-head coincidence camera: a review Eur. J. Nucl. Med. 28 2001 763 778
2. M.I. Block, G.A. Patterson, R.S. Sundaresan, M.S. Bailey, F.L. Flanagan, and F. Dehdashti Improvement in staging of esophageal cancer with the addition of positron emission tomography Ann. Thor. Surg. 64 1997 770 776
3. E.L. Boren, D. Delbeke, J.A. Patton, and M.P. Sandler Comparison of FDG-PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch NAI (TI) crystals in patients with suspected body malignancies Eur. J. Nucl. Med. 26 1999 379 387
4. J. Bradley, W.L. Thorstad, S. Mutic, T.R. Miller, F. Dehdashti, and B.A. Siegel Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 59 2004 78 86
5. I. Buchmann, M. Reinhardt, K. Elsner, D. Bunjes, C. Altehoerfer, and J. Finke 2-(fluorine-18) Fluoro-2-Deoxy-D-Glucose positron emission tomography in the detection and staging of malignant lymphoma. A Bicenter trial Cancer 91 2001 889 899
6. 18FDG-hybrid PET fusion Int. J. Radiat. Oncol. Biol. Phys. 51 2001 923 931
7. J.Y. Choi, K.H. Lee, Y.M. Shim, K.S. Lee, J.J. Kim, and S.E. Kim Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG-PET J. Nucl. Med. 41 2000 808 815
8. I.F. Ciernick, E. Dizendorf, B.G. Baumert, B. Reiner, C. Burger, and J.B. Davis Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int. J. Radiat. Oncol. Biol. Phys. 57 2003 853 863
9. e Congr̀s National de la SFRO Cancer/Radiother 6 Suppl 1 2002 S101
10. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goiten, and J.E. Mundenrider Tolerance of normal tissue to therapeutic irradiation Int. J. Radiat. Oncol. Biol. Phys. 21 1991 109 122
11. Y.E. Erdi, K. Rosenweig, A.K. Erdi, H.A. Macapinlac, Y.C. Hu, and L.E. Braban Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) Radiother. Oncol. 62 2002 51 60
12. P. Flamen, A. Lerut, E. Van Cutsem, W. De Wever, M. Peeters, and S. Stroobants Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J. Clin. Oncol. 18 2000 3202 3210
13. F.L. Flanagan, F. Dehdashti, B.A. Siegel, D.D. Trask, S.R. Sundaresan, and G.A. Patterson Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography Am. J. Roentgenol. 168 1997 417 424
14. B.A. Frass The development of conformal radiation therapy Med. Phys. 22 1995 1911 1921
15. 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers Int. J. Radiat. Oncol. Biol. Phys. 49 2001 1249 1257
16. G.W. Goerres, E. Karnel, T.N. Heidelberg, M.R. Schwiter, C. Burger, and G.K. Von Schultless PET-CT image co-registration in the thorax: influence of respiration Eur. J. Nucl. Med. 29 2002 351 360
17. M.V. Graham, J.A. Purdy, B. Emami, W. Harms, W. Bosch, and M.A. Lockett Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small-cell lung cancer (NSCLC) Int. J. Radiat. Oncol. Biol. Phys. 45 1999 323 329
18. V. Gregoire Is there any future in radiotherapy planning without the use of PET: unravelling the myth... Radiother. Oncol. 74 2004 261 263
19. A. Howard, M.P. Mehta, M.A. Ritter, K.A. Bradley, W.A. Tom, and R.J. Chappell The value of PET/CT in Gross Tumor Volume delineation in lung and esophagus cancer [abstract] Int. J. Radiat. Oncol. Biol. Phys. 60 Suppl 1 2004 S536 S537
20. B. Hueltenschmidt, M.L. Sautter-Bihl, O. Lang, F.D. Maul, J. Fisher, and H.G. Mergenthaler Whole body positron emission tomography in the treatment of Hodgkin disease Cancer 91 2001 302 310
21. International commission on radiation units and measurements ICRU Report 50: Prescribing, recording, and reporting photon beam therapy 1993 International commission in radiation units and measurements Bethesda, MD
22. International commission on radiation units and measurements ICRU Report 62: Prescribing, recording, and reporting photon beam therapy (supplement to ICRU Report 50) 1999 International commission in radiation units and measurements Bethesda, MD
23. G. Jerusalem, Y. Beguin, F. Najjar, R. Hustinx, M.F. Fassotte, and P. Rigo Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL) Ann. Oncol. 12 2001 825 830
24. H. Kato, T. Miyazaki, M. Nakajima, J. Takita, H. Kimura, and A. Faried The incremental effect of positron emission tomography on diagnostic accouracy in the initial staging of esophageal carcinoma Cancer 103 2005 148 156
25. K. Kim, S.J. Park, B.T. Kim, K.S. Lee, and Y.M. Shim Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography An. Thor. Surg. 71 2001 290 294
26. T. Leong, C. Everitt, K. Yuerr, S. Condron, D. Binns, and A. Pitman A prospective study to evaluate the impact of Coregistered PET/CT images on radiotherapy treatment planning for esophageal cancer [abstract] Int. J. Radiat. Oncol. Biol. Phys. 60 Suppl 1 2004 S139 S140
27. J.D. Luketich, P.R. Schauer, C.C. Meltzer, R.J. Landreneau, G.K. Urso, and D.W. Townsend Role of positron emission tomography in staging esophageal cancer Ann. Thor. Surg. 64 1997 765 769
28. M.P. Mac Manus, R.J. Hicks, D.L. Ball, V. Kalff, J.P. Matthews, and E. Salminen F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with non-small-cell lung carcinoma Cancer 92 2001 886 895
29. C.C. Meltzer, J.D. Luketich, D. Friedman, M. Charron, D. Strollo, and M. Meehan Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography Clin. Nucl. Med. 25 2000 882 887
30. S. Mutic, R.S. Malyapa, P.W. Grigsby, F. Dehdashti, T.R. Miller, and I. Zoberi PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study Int. J. Radiat. Oncol. Biol. Phys. 55 2003 28 35
31. K. Narayan, R.J. Hicks, T. Jobling, D. Bernshaw, and A.F. Mc Kenzie A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact of treatment Int. J. Gynecol. Cancer 11 2001 263 271
32. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis Int. J. Radiat. Oncol. Biol. Phys. 44 1999 593 597
33. 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas Int. J. Radiat. Oncol. Biol. Phys. 53 2002 1051 1057
34. S.C. Rankin, H. Taylor, G.J. Cook, and R. Mason Computed tomography and positron emission tomography in the pre-operative staging of esophageal carcinoma Clin. Radiol. 53 1998 659 665
35. M.J. Reinhardt, C. Ehritt-Braum, D. Vogelgesang, C. Ihling, S. Hogerle, and M. Mix Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG-PET Radiol. 218 2001 776 782
36. P.D. Shreve, R.S. Steventon, E.C. Deters, P.V. Kison, M.D. Gross, and R.L. Wahl Oncologic diagnosis with 2-[fluorine-18] fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner Radiol. 207 1998 431 437
37. J.N. Talbot, C. Haioun, J.D. Rain, M. Meignan, M. Wioland, and J.L. Misset 18F]-FDG positron imaging in clinical management of lymphoma patients Crit. Rev. Oncol. Hematol. 38 2001 193 221
38. M. Tatsumi, K. Yutani, Y. Watanabe, S. Miyoshi, N. Tomiyama, and T. Johkoh Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG-PET J. Nucl. Med. 40 1999 566 573
39. 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small-cell lung cancer Radiother. Oncol. 55 2000 317 324
40. O. Vrieze, K. Haustermans, W. De Wever, T. Lerut, E. Van Cutsem, and N. Etors Is there a role for FDG-PET in radiotherapy planning in esophageal carcinoma? Radiother. Oncol. 73 2004 269 275
41. W.A. Weber, J. Neverve, J. Sklarek, S.I. Ziegler, P. Bartenstein, and B. King Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system Eur. J. Nucl. Med. 26 1999 388 395
42. T.C. Yen, K.K. Ng, S.Y. Ma, H.H. Chou, C.S. Tsai, and S. Hsueh Value of dual-phase 2-fluro-2-deoxy-D-glucose positron emission tomography in cervical cancer J. Clin. Oncol. 21 2003 3651 3658
43. M. Zimny, H.J. Kaiser, U. Cremerius, P. Reinartz, M. Scheckenberger, and O. Sabri Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection Eur. J. Nucl. Med. 26 1999 818 823